A randomised controlled pilot trial to assess the efficacy of Intravesical Pethidine in treating bladder spasm in children who have undergone Ureteric Reimplantation Surgery
Princess Margaret Hospital
40 participants
Nov 1, 2016
Interventional
Conditions
Summary
Aim: The aim is to assess the efficacy of intravesical pethidine in controlling bladder spasm in children after ureteric reimplantation surgery. Hypothesis: Children receiving intravesical pethidine will have less episodes of bladder spasm requiring therapy, lower pain scores and lower intravenous opioid requirements compared with children receiving placebo (saline) following ureteric reimplantation surgery
Eligibility
Inclusion Criteria1
- Children undergoing ureteric reimplantation surgery under general anaesthetic at Princess Margaret Hospital, Perth, Western Australia. Children will be enrolled pre-operatively and eligibility will not be dependent on whether they experience bladder spasm.
Exclusion Criteria1
- Children whose parents refuse informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Pethidine - intravesical, 1 mg/kg, as required up to every 4 hours post-operatively for bladder spasm until spasm resolved. Interventional drug to be administered by nursing staff and as such adherence will be monitored. Decision on whether drug to be given also made by nursing staff and/or clinician if available.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12616001388404